This article was recently published in the Journal of Global Health Authors:Rifat Atun, Harvard T.H. Chan School of Public Health, Boston, USA, Sachin Silva , Imperial College, London, Mthuli Ncube, Project Leader on RethinkHIV and Professor of Public Policy at Blavatnik School of government, University of Oxford and Anna Vassall, LSHTM, London
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.